Rubella infection during pregnancy is one of the most well-established causes of permanent hearing loss in children, and it has been since an Australian ophthalmologist first connected the dots in 1941. When a pregnant person contracts rubella in the first trimester, the virus can cross the placenta and damage the developing fetus, producing a cluster of birth defects known as congenital rubella syndrome, or CRS. Hearing loss is the single most common feature of CRS, and it is often severe and irreversible. The good news is that rubella vaccination has already cut global CRS cases by roughly two-thirds over the past decade, but tens of thousands of affected births still occur each year in regions where vaccine coverage lags.
How Rubella Damages a Developing Baby’s Hearing
Rubella is mild for most people who catch it after birth. A rash, low fever, and joint aches last a few days and clear on their own. The danger is almost entirely to a fetus exposed in utero, because the virus is teratogenic: it disrupts the normal formation of organs during the critical early weeks of development. The inner ear, heart, and eyes are all actively forming during the first trimester, which is why those structures bear the brunt of the damage.
Hearing loss from CRS is sensorineural, meaning it originates in the inner ear rather than the middle ear. The rubella virus appears to damage the cochlea, the snail-shaped organ that converts sound vibrations into nerve signals. Research into the molecular pathways involved suggests that viruses capable of causing congenital hearing loss interfere with key molecules governing cochlear development, including those responsible for producing the delicate hair cells that detect sound.1PubMed Central. Embryonic Origins of Virus-Induced Hearing Loss: Overview of Molecular Etiology Once those hair cells are destroyed or never properly formed, they do not regenerate, which is why the hearing loss is permanent.
Timing matters enormously. Infection in the first trimester carries the highest risk of birth defects and fetal death, with the probability of severe outcomes declining after about 20 weeks of gestation.2PubMed. Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy In one study of children born to mothers who had symptomatic rubella in the first trimester, hearing loss was confirmed in half of the children by age three.3PubMed. Hearing defects in children born of mothers suffering from rubella in the first trimester of pregnancy That is a striking rate, and it underscores why preventing rubella exposure during early pregnancy is so important.
What the Hearing Loss Looks and Sounds Like
CRS-related hearing loss tends to follow a recognizable pattern. It is usually bilateral, meaning both ears are affected, and symmetric, meaning the degree of loss is similar on each side. Audiograms of affected individuals often show a fairly uniform loss across the full range of sound frequencies rather than the selective high-frequency or low-frequency loss seen in some other conditions. In one long-term study, the average hearing loss across the speech-relevant range of 250 to 4,000 Hz was about 93 decibels, which qualifies as severe to profound.4PubMed Central. Onset and severity of hearing loss due to congenital rubella infection At that level, a person cannot hear normal conversation and may perceive only very loud sounds, if any.
That said, not every child with CRS has the same degree of hearing loss. Audiological profiling of infants with confirmed CRS has shown that the severity can range from mild to profound, even though the underlying cause is the same virus.5Journal of Otolaryngology-ENT Research. Profiling of Audiological Characteristics in Infants with Congenital Rubella Syndrome The variation probably reflects differences in the timing and intensity of viral exposure, the mother’s immune response, and individual fetal susceptibility. A child whose mother was infected at six weeks of gestation may have a very different outcome from one whose mother was infected at fourteen weeks.
Hearing impairment is also frequently accompanied by other CRS-related problems. In a clinic-based study from Indonesia, the most common presentations among newborns screened for CRS included hearing impairment alone, the combination of congenital heart disease with hearing impairment, and the triple combination of heart disease, eye abnormalities, and hearing impairment.6PubMed Central. Congenital Rubella Syndrome profile of audiology outpatient clinic in Surabaya, Indonesia The overlap means that a child diagnosed with one CRS feature should be evaluated for the others, and vice versa.
Hearing Loss That Shows Up Late
One of the more unsettling aspects of CRS is that not all of its effects are visible at birth. Some manifestations are “delayed,” appearing months or years after the child seems to have escaped the worst outcomes. Hearing loss is specifically listed among these delayed manifestations, alongside conditions such as diabetes, thyroid disease, glaucoma, and a rare progressive brain inflammation.7Reviews of Infectious Diseases. Delayed Manifestations of Congenital Rubella
This means a newborn who passes an initial hearing screen could still develop rubella-related hearing loss in early childhood. Some researchers believe the virus persists in the inner ear and continues to damage tissue long after birth. Others point to a slow inflammatory process triggered during fetal development that worsens over time. Whatever the mechanism, it highlights the importance of repeated hearing evaluations for any child with confirmed or suspected CRS, not just a single test at birth.
Screening and Diagnosis
Identifying CRS-related hearing loss involves two parallel tracks: confirming that the child has hearing loss, and confirming that rubella was the cause.
For the hearing side, standard newborn hearing screening tools are the first step. These include otoacoustic emissions (OAE) tests and automated auditory brainstem response (AABR) tests. In a screening program in Yogyakarta, Indonesia, about 60 percent of newborns initially returned a “refer” result on OAE, meaning further testing was needed. After follow-up, a smaller number were confirmed to have sensorineural hearing loss, and among those, at least one case was confirmed as CRS through rubella antibody testing.8Journal of Pediatric Infectious Diseases. Congenital Rubella Syndrome Screening for Newborn in Yogyakarta, Indonesia That study recommended targeted hearing screening for infants suspected of CRS in settings where universal screening is not yet mandatory, and rubella antibody testing for any infant under one year with suspected CRS.
On the rubella confirmation side, blood tests for rubella-specific IgM antibodies are the standard approach. A positive IgM result in a young infant strongly suggests recent or congenital infection. For more definitive diagnosis, PCR testing can detect rubella virus RNA in clinical samples such as throat swabs or even lens tissue removed during cataract surgery.9PubMed Central. Use of PCR for prenatal and postnatal diagnosis of congenital rubella One case study demonstrated positive PCR results from both throat swab and eye-lens specimens in a CRS patient with bilateral deafness, confirming the viral link.10Indonesian Journal of Tropical and Infectious Disease. Polymerase Chain Reaction and Serology Test to Detect Rubella Virus in Congenital Rubella Syndrome Patients with Hearing Loss
Early diagnosis matters because it opens the door to interventions like hearing aids or cochlear implants during the window when language acquisition is most active. Late diagnosis, unfortunately, remains common in many parts of the world, particularly where newborn hearing screening programs are underfunded or absent.
Can the Hearing Loss Be Treated?
CRS-related hearing loss cannot be reversed, but its impact on communication and development can be substantially reduced with the right interventions. For children with mild to moderate loss, hearing aids may be sufficient. For those with severe to profound loss, cochlear implants are the primary option.
Cochlear implants bypass the damaged hair cells in the inner ear and stimulate the auditory nerve directly with electrical signals. A study evaluating cochlear implant outcomes in CRS patients found progressive improvement over time: auditory performance scores rose steadily from six months through 24 months after implantation.11International Journal of Health Sciences. Cochlear implants evaluation for congenital rubella syndrome patients in Dr. Soetomo Academic Medical Center These results are encouraging, though outcomes vary depending on the age at implantation, the presence of other CRS-related disabilities, and how consistently the child receives auditory rehabilitation therapy afterward.
The challenge is timing. Guidelines generally recommend identifying hearing loss by one month of age, confirming it by three months, and beginning intervention by six months. When CRS is diagnosed late, as it often is in low-resource settings, children may not receive hearing aids or implants until after the most sensitive period for language development has passed. A case report described a child with CRS-related hearing loss who was fitted with hearing aids only intermittently and whose mother reported the child still could not hear effectively, underscoring the consequences of delayed and inconsistent intervention.12Aulad: Journal on Early Childhood. in Late Diagnosed Congenital Hearing Loss with Delayed Speech: A Case Report
Vaccination Is the Real Prevention
Treating CRS is expensive and imperfect. Preventing it is straightforward: vaccinate against rubella before pregnancy. The rubella vaccine, typically given as part of the measles-mumps-rubella (MMR) combination, has been one of the most effective vaccines in history at eliminating a cause of birth defects.
The story begins with the massive rubella epidemic that swept the United States and other countries in the early 1960s, which left thousands of children with CRS and galvanized the development of a rubella vaccine.13Clinical Infectious Diseases. Making Vaccination Policy: The Experience with Rubella The connection between rubella in pregnancy and congenital defects had actually been established two decades earlier by Sir Norman Gregg, an Australian ophthalmologist who noticed an unusual cluster of cataracts in babies born after a rubella outbreak.14PubMed Central. Perinatal lessons from the past: Sir Norman Gregg, ChM, MC, of Sydney (1892-1966) and rubella embryopathy But it took the sheer scale of the 1960s epidemic to trigger the political and scientific urgency needed to develop and deploy a vaccine.
The results have been dramatic. Between 2012 and 2022, the number of countries including rubella vaccine in their immunization schedules rose from 132 to 175, and reported rubella cases worldwide fell by 81 percent.15Centers for Disease Control and Prevention. Progress Toward Rubella and Congenital Rubella Syndrome Elimination — Worldwide, 2012–2022 The estimated global number of CRS births dropped from roughly 100,000 per year around 2010 to about 32,000 in 2019, a two-thirds reduction driven largely by vaccine introductions in Southeast Asia and the Western Pacific.16PubMed Central. Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019
Countries that achieve high vaccination coverage can essentially eliminate rubella transmission. A 2024 seroprevalence study in Belgrade found rubella antibody positivity of about 95 percent across all age groups, consistent with the absence of rubella cases in Serbia for the preceding three years.17PubMed Central. Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024 That level of herd immunity effectively shields the small number of unvaccinated people, including pregnant individuals, from encountering the virus.
The Gap That Remains
The global picture is not uniformly rosy. In 2022, rubella vaccination coverage in low-income countries was just 27 percent, compared with 93 percent in high-income countries.15Centers for Disease Control and Prevention. Progress Toward Rubella and Congenital Rubella Syndrome Elimination — Worldwide, 2012–2022 The WHO African and Eastern Mediterranean regions carry the heaviest CRS burden, with incidence rates many times higher than in regions where more than 95 percent of births occur in countries with rubella vaccination programs.16PubMed Central. Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019
Cost is a common concern, but economic analyses consistently show that rubella vaccination programs save money in the long run. CRS is expensive to manage: estimated costs range from a few thousand dollars per case annually in middle-income countries to up to $140,000 over a lifetime in high-income countries, covering cardiac surgery, hearing devices, vision care, special education, and lost productivity.18PubMed Central. Health economics of rubella: a systematic review to assess the value of rubella vaccination Modelling studies of rubella elimination in low- and middle-income countries have found that intensified vaccination investment is the most cost-effective scenario compared with simply maintaining current trends.19PubMed Central. Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
Protecting Women Who Missed Vaccination
Childhood vaccination is the backbone of rubella prevention, but it does not help a woman who arrives at her first prenatal visit without immunity. One practical solution is to test for rubella antibodies during pregnancy and vaccinate susceptible women shortly after delivery, before they become pregnant again. This approach was advocated as early as 1970, when researchers noted that the first days postpartum are an ideal window because the risk of a new pregnancy is extremely low.20The Lancet. POST-PARTUM VACCINATION OF RUBELLA-SUSCEPTIBLE WOMEN
A Japanese perinatal center put this into practice and found that while the overall rubella seropositivity rate among pregnant women was about 93 percent, roughly one in five had antibody levels low enough to warrant postpartum vaccination. Among those vaccinated, the response rate was 100 percent in women with the lowest pre-vaccination titers, and no severe adverse reactions were observed.21PubMed. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center Postpartum vaccination is safe for breastfeeding mothers and protects future pregnancies.
What about accidental rubella vaccination during pregnancy? The rubella vaccine is a live attenuated virus, and current guidelines say it should not be given to pregnant individuals. But accidents happen, and the data on this are reassuring. The U.S. CDC maintained a registry of 321 susceptible pregnant women who received the vaccine during pregnancy or shortly before conception between 1971 and 1989. None of the infants had CRS-related birth defects. A separate prospective study comparing outcomes in 94 women who received rubella vaccine while pregnant against 94 unvaccinated controls found no differences in rates of birth defects, birth weight, developmental milestones, or hearing test results.22Pediatrics. Congenital Rubella Syndrome Following Rubella Vaccination During Pregnancy Subsequent reports covering more than 2,600 women of unknown immune status before accidental vaccination did not identify a single case of CRS. So while the recommendation to avoid vaccination during pregnancy stands as a precaution, inadvertent exposure is not a reason to terminate a pregnancy.
Rubella Versus CMV as a Cause of Childhood Hearing Loss
Rubella is not the only infection that can damage a baby’s hearing before birth. Cytomegalovirus (CMV) is actually the most common infectious cause of congenital hearing loss in countries where rubella has been largely eliminated through vaccination. The two viruses produce somewhat different patterns of hearing damage. In a comparative study, roughly 57 percent of children with rubella-related hearing loss had profound sensorineural loss, while 40 percent of CMV-infected children had moderately severe loss.23International Journal of Research in Medical Sciences. Association of sensorineural hearing loss in pediatric patients with CMV and Rubella infection In other words, rubella tends to hit harder when it hits.
CMV-related hearing loss can also be progressive and fluctuating, meaning it may worsen over time or vary from one test to the next. Rubella-related loss is more typically stable after the initial damage, though delayed onset remains a possibility as noted earlier. There is no vaccine for CMV yet, which is one reason it has taken rubella’s place as the leading infectious cause of congenital hearing loss in vaccinated populations. The contrast is a useful reminder that rubella vaccination does not eliminate all infectious causes of hearing loss in newborns, but it removes the one we have the simplest tool to prevent.
Both viruses appear to disrupt some of the same molecular pathways involved in cochlear development, particularly those governing the formation of hair cells and supporting structures in the inner ear.1PubMed Central. Embryonic Origins of Virus-Induced Hearing Loss: Overview of Molecular Etiology Understanding those shared pathways is an active area of research, with the hope that it could eventually lead to therapies that protect the inner ear even when a viral infection occurs.